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Introduction 
Diabetes mellitus is not one disease with a defined 
genetic origin, but many diseases with related symptoms. 
Most cases of this disease can be classified as Type I, 
insulin dependent (usually juvenile onset) , or Type II, 
insulin non-dependent (usually adult onset) 1 The term, 
diabetes mellitus, was first coined in the seventeenth cen-
tury when it was observed that some individuals, despite the 
large intake of food were suffering from substantial weight 
loss. It was postulated that the body was dissolving itself 
and was pouring out through the urinary tract. Thus, the 
Greek word diabetes, meaning "running through" and the Latin 
word mellitus meaning "honey" or "sweetness" were used 
together to describe the major symptom of diabetes, the 
excretion of large amounts of sweet urine. It was not until 
the late 1800's that researchers discovered that the oancreas 
played an important role in this disease. The diabetic 
condition was induced in experimental animals when the 
pancreas was removed. Some thirty years later, in 1921, 
Banting and Best, while working with pancreatic extracts, 
d. d . 1 · 
2 
iscovere insu in. Up until the discovery of insulin, 
diabetics survived not more than a few years after diagnosis. 
2. 
Treatment with insulin prevented death from diabetic coma 
and controlled many of the overt symptoms of the disease. 
With the increase in the life expectancy of individuals with 
diabetes came the discovery of many comolications such as ·- ' 
cardiovascular disease, retinopathy, and kidney disease. 
Since Banting's and Best's discovery of insulin more has 
been learned about the complexity of the pancreas. It is a 
bifunctional organ with both exocrine and endocrine functions. 
The endocrine constituent is composed of the islets of 
Langerhans. The islets contain a variety of cell types: the 
alpha cells which secrete glucagon; beta cells which secrete 
insulin; delta cells which secrete somatostatin; and the PP 
cells which secrete pancreatic polypeptide. Although all may 
be indirectly involved in diabetes, research is primarily 
interested in the beta cells and their role in diabetes. 
Today, diabetes affects almost 5% of the oopulation. It 
is the third ranking cause of death in the United States, 
after heart disease and cancer. In 1975, the National Com-
mission on Diabetes related some of its findings to Congress. 
The statistics and findings werP.: 
Diabetics are 25 times more prone to blindness than 
nonctiabetics; 17 times more prone to kidney disease, 5 
times more prone to gangrene; and 2 times more prone to 
heart disease. 
The life expectancy among oeople with diabetes is 
one third less than that of the general population. 
Women are 50% more likely than men to have diabetes, 
non-whites are 20% more likely than whites to have 
diabetes. 
3. 
The enconomic toll of the disease, not counting its 
complications, is estimated to be $ 5 .3 billion every 
year.3 
Based on its findings, the Commisssion advised that a 
long range plan be put into effect. They saw the need for 
diabetes research programs, diabetes training centers, and 
diabetes education. The Commission formed the National 
Diabetic Advisory Board. The Boards mission was to implement 
h . . l 3 t e Commissions p ans. 
Since the findin9s of the Commission, research in dia-
betes has continued to flourish. Several approaches to the 
problem have been taken; one course of action has been toward 
finding the cause or causes for diabetes. Over the years 
several ideas have been advanced to try and explain the 
etiology of this disease. One suggested that the immune 
system may be responsible, while another suggested that an 
individual must have the correct genetic predisposition to 
develop diabetes, and still another suggested that the cause 
lies in an infectious etioloty. 
4, 5 
As far back as 1 899, when Harris reported that diabetes 
developed in a patient shortly after an infection with mumps 
virus, researchers have considered the oossibility of virus­
induced diabetes.6 Other viruses that have been associated 
with diabetes include: group B coxsackievirus; reo; rubella; 
influenza; cytomegalovirus; polio; measles; and tick borne 
encephali tus. 7 • 8 
4. 
Evidence supporting the involvement of these common 
human viruses is minimal at most, with one exception. Con-
siderable evidence has now accumulated whic:1 suggests that the 
group B coxsackieviruses cause diabetes in man. In 1969, 
Gamble and associates found that titers of neutralizing anti-
body to CB4 were higher in newly diagnosed diabetic patients 
when compared to non-diabetic controls. The same correlation 
q 
did not exist with the other common viruses they tested.� 
Then in 1979, Yoon and associates, working with a 10 year old 
diabetic found that the patient's diabetes was probably virus 
induced. The patient was hospitalized with diabetic ketoacid-
osis and 3 days later he died. Studies showed lymphocytic 
infiltration of the islets of Langerhans and necrosis of beta 
cells. Serological analysis showed a rise in neutralizing 
antibody to vi��s frcm less than 4 on the second day in the 
hospital to 32 on the day of his death. Virus was isolated 
from the liver, pancreas, and other organs. 
d 
. 
4 
10 
ata showed that the virus was CB . 
Neutralization 
Most evidence supporting the involvement of viruses in 
diabetes has been provided by studies with experimental 
animals, especially mice. The M variant of encephalo-
myocarditis (MEMC) virus has proved to be an excellent model 
for viral induced diabetes using "susceptible" and "nonsus-
ceptible" strains of mice and the hybrids. In susceptible 
strains of mice, the virus infects the insulin producing beta 
cell of the pancreas, producing hypoinsulinemia, hypergly-
cemia, and abnormal glucose tolerance tests. The nonsuscep-
5. 
tible strains become infected, however, there is no apparent 
infection in the beta cells and diabetes-like symptoms do not 
develop. The determining factor in susceptibility appears to 
be in the genetic prectisposi tion of the host to allow virus 
replication in the beta cells. 
13 
The MEMC virus model has proved useful, however, EMC 
virus is not a co11Unon pathogen of humans. Considerable 
interest has now focused on the group B coxsackieviruses 
(CB). CB viruses are related to the EMC virus; they are both 
Picornaviruses. Coxsackievirus, group B, type 4 (CB4) 
infects mice and produces a generalized disease very similar 
to that produced in man. 
7 
species. 
Also, CB4 is pancreatropic for both 
In 1980, Webb and associates suggested that the gene or 
genes which control the susceptibility of mice to MEMC virus-
induced diabetes may also be responsible for the induction of 
diabetes by CB4 virus. Using mice that were susceptible and 
nonsusceptible to the MEMC virus; they inoculated each group 
of mice with CB4 virus. There was a positive correlation 
between MEMC virus susceptibility and CB4 induced beta cell 
degranulation. They concluded that physically and chemically 
similar viruses, such as MEMC and CB4, may share a co11Unon 
receptor on the cell surface, and as a result the host res-
. · 
1 
12 
ponse would be s1m1 ar. A number of important contribu-
tions by others had preceeded their observations and heloed 
establish the relationship between CB4 and diabetes-like 
disease in animals. 
6. 
In 1974, Coleman and associates induced diabetes in 20%-
30% of the adult male CD-1 mice that they inoculated with 
CB4 virus. Histology showed slight damage to both the islet 
and acinar tissues. 13 Ross and Notkins, however, reported 
the opposite results. Using prototype strains of CBl, CB3, 
CB4, and CBS viruses and CD-1 male mice, they produced hyper-
amylasaemia and a decrease in the amylase content of the 
pancreas. The non-fasting glucose levels and glucose toler-
ance test, however, were normal under a variety of experimen-
tal conditions. The hyperamylasaemia found during acute 
infection supported the pathological changes of acinar pan-
creatitis. Non-fasting glucose levels and glucose tolerance 
test failed to reveal evidence of glucose intolerance. 
Furthermore, they found no beta cell damage. They concluded 
that there was not enough evidence to support the theory that 
. d. b 1 . k d 
· · 14 CB4 viruses cause 1a etes- 1 e syn rome in mice. Data of 
others support these observations that CB4 does not induce 
d. 1 · k d. . . 15 1abetes- 1 e 1sease in mice. In another article that 
same year, Ross and Notkins suggested that variations in the 
virus or in susceptibility of the host to infection might be 
important factors in the production of diabetes and might 
explain conflicting results�6 
In an effort to explain conflicting results, some 
researchers turned their efforts towards determining if there 
were variations in the susceptibility of the host to infec-
tion. Specifically, they wanted to know if the pancreas was 
susceptible to various viruses and if these viruses would 
replicate in the pancreas. As early as 1951, Pappenheimer 
reported severe pathological changes in the pancreas of 
sexually mature mice when inoculated with CBS virus. He 
7. 
observed massive necrosis of the acinar tissue, but the 
islets of Langerhans were resistant to destruction.
1 7  
Then 
in 1971, Burch and associates inoculated mice with CB4 virus. 
Histological studies showed significant cellular alterations 
in the exocrine and endocrine pancreas. Electron micrographs 
showed degranulation and cellular disruption of the islet 
cells. He postulated that viral pancreatitis may cause sub-
clinical diabetes as well as overt diabetes mellitus in 
varying degrees. 18 It was not until the late 1970's that 
there was substantia l evidence that the pancreas was suscep-
tible to infection and that the CB viruses actually replicated 
in the pancreas. In 1978, using cultured human beta cells 
and radioinununoassay, Yoon and associates showed intracellular 
inununoreactive insulin decreased rapidly beginning at 24 hours 
post infection with a CB3 virus. The decrease was roughly 
paralleled with the increase in viral titer. By use of 
double-label antibody, they were able to demonstrate that the 
beta cells in these cultures were susceptible to infection 
by CB3 virus. In conclusion, they postulated that in vitro 
human beta cells would replicate the CB3 virus.19 Then in 
1979, they inoculated mice with a human isolate of CB4. The 
mice became hyperglycemic with inflammatory cells in the 
islets and beta cell necrosis. They then stained the pancreas 
8. 
sections with florescein-label antiviral antibody and found 
CB4 viral antigens in the beta cells.lo Around the same 
time, Prince and associates demonstrated that mumps virus 
would also replicate in cultured human beta cells.20 
Yoon and associates con eluded " ... the most plausible 
explanation for these conflicting reports (concerning CB 
viral-induced diabetes) would appear to be that in mice, 
most strains of CB virus are minimumally beta tropic and that 
if beta cells are damaged, the number is usually insufficient 
to produce substantial alterations in glucose metabolism". 21 
With this in mind, they passed virus in beta cells. Experi-
mental animals were inoculated with passed and unpassed virus. 
The unpassed virus failed to raise the glucose index
a 
above 
control valves. Virus passed 3 times in the beta cells 
showed elevated glucose indexes; virus passed 5 times induced 
diabetes in 35% of the animals; virus passed 14 times induced 
diabetes in 80% of the animals. The unpassed virus failed to 
produce diabetes even when high titers of virus were used. 
Yoon and associates noted that only the beta cells of some 
strains of mice replicated the virus. They concluded that 
the 9assage history of the virus and the strain of the host 
a
Glucose index was used by 
weight to the presence of 
cose index is defined as: 
+ (2 x GTT day 17) + (1 X 
Ross and Notkins to give added 
non-fasting hyperglycemia. Glu­
(4 x NF day 14) + (3 x NF day 7) 
GTT day 10) divided by 10. 
Ross, M.E., T. Onodera, K.S. Brown, A.L. Notkins. Virus­
induced Diabetes Mellitus IV. Diabetes 25: 190, 1976. 
9. 
influence the development of diabetes.21 
Much work has been done to determine the susceptibility 
of the various strains of mice to diabetes, however, little 
definitive work has been done with the passage history of the 
virus, yet its influence in the consequence of viral patho-
genesis has been known since 1952. Dalldorf and associates, 
while working with viruses and the pancreas, suggested that 
anatomic comparisons should take into account the past his-
tories of the strains of viruses and the methods used in 
their propagation. 22 Lansdown worked with CB virus and 
concluded, as Ross and Notkins, that CB virus does not 
produce diabetes-like changes in islet cells. However, he 
said that it was apparent that much further work is required 
to understand the variations in the pathogenicity of the CB 
. 23 viruses. 
Hartig and Webb in 1983, showed that one human isolate 
of CB4, Edwards, contained several strains of virions. They 
were able to isolate 3 strains which were designated: El, E2, 
and E3. The 3 strains were similar serologically, they 
showed identical plaque morphology, and replicated to similar 
levels in the mouse pancreas. The three isolates varied in 
their capacity to accumulate virus antigen within the islet 
cells of genetically similar mice. They concluded that the 
difference in the infecting particle is probably a genetic 
difference. The pathological consequence and expression of 
any diabetogenic potential is,therefore,dependent on virus 
strain selection. 24 
10. 
In another study, Hartig and Webb examined the biological 
properties of CB4 Edwards, El, E2, and E3 during the acute 
phase of infection. They showed that although the isolates 
were similar serologically, they differed in their biological 
properties. The original virus, CB4 Edwards, induced an 
increase in plasma amylase in SWR and 6J mice. Ar:tylase con-
centrations were not affected in the SWR mice inoculated with 
the E2 isolate. El and E2 did depress blood glucose levels, 
yet failed to produce a rise in plasma insulin levels in the 
SWR mice. The CB4 Edwards, however, did induce a rise in 
plasma insulin levels in this strain. El also produced a 
hypoglycaemic state in the 6J mice without altering plasma 
insulin concentrations. Hartig and Webb concluded that ... 
"the data collected demonstrate differences between CB4 virion 
populations and the pathologies which can result from infect-
25 
ion with specific virions as well as the total virus pool." 
Most evidence to date clearly indicates that CB4 virus 
can affect the pancreas of both man and mice during acute 
infection. Yet, conflicting evidence exists relative to the 
consequence of the infection in both man and mice. The study 
described here attempted to provide definitive evidence on the 
relative role of the virus isolate (i.e. heterogenous virion 
populations vs. purified clones) in induction of prolonged 
diabetes-like disease in mice. 
Materials and Methods 
I. VirUEeS 
Six isolates of the coxsackievirus, group B, type 4 
(CB4) were used in this study: human isolate �owers (Pow) 
human isolate Edwards (Edw); purified isolate Edwards 1 (El) 
purified isolate Edwards 2 (E2); ourified isolate Edwards 3 
(E3); and purified isolate Edwards 2 passed in cultured mouse 
islet cells (E2i) . Although some of these viruses may be 
subtypes or strains, all have been called isolates here, 
since insufficient data exist to allow the differentiation of 
one from the other. 
The virus, CB4 Pow was originally isolated by Kibrick 
and Benirschke in 1958 from an infant who died from resoira­
tory failure and gastrointestinal and oulmonarv hemorrhages.26 
The virus was isolated from myocardial, liver, and soinal 
cord tissue by growth in cultured monkey renal cells and 
identified as a CB4 by neutralization with type-specific 
antisera. The virus was obtained from Kibrick and pools of 
the virus were obtained using cultured Hela cells. 
The virus, CB4 Edw was also originally isolated by 
. 26 
Kibrick and Benirschke in 1958. It was isolated from 
heart, liver, and spleen tissue of an infant who died from 
12. 
encephalohepatomyocarditis. The virus was similarily grown 
and identified as CB4. Webb and associates have documented 
the passage history of CB4 Edw as well as its pathogenesis in 
various strains of mice.27, 12 
Hartig and Webb purified the CB4 Edw; three plaque 
purified isolates were chosen. These were designated E1, E
2
, 
and E3. The passage history of these three isolates was 
recently documented by Hartig and Webb. 24 
The E2 i isolate was the product of passing the E2 
isolate sequentially 5 times in cultured islet cells derived 
from C57BL/6J mice. 
The titer of the various viruses was determined using a 
plaque assay. Cultured Buffalo Green Monkey (BGM) kidnev 
cells and methyl cellulose, an overlay medium, were used in 
this assay. 
II. Mice 
Mice of the outbred strain CD-1 were obtained from 
Charles River Breeding Laboratories (Dublin, Virginia). The 
mice were housed 5 to a cage and fed either Purina Lab Chow 
(phase I animals) or Purina Mouse Chow (phase II animals). 
The animals were allowed food and water ad li_bitum. Light(l2 :12) 
and temperature (25°c) were maintained in the animal facilitv. 
The mice were maintained and used according to the guidelines 
established by the National Research Council in DHEW 
publication number (NIH) 73-23. 
13. 
III. Experimental Design 
In the first phase of the experiment, 6- 7 week old male 
CD-1 mice were were divided into 6 groups with 20 animals in 
each group. Each group was inoculated i� with 1 x 10 4 pfu 
of either Pow, Edw, E1, E2, E3 or E2i isolate of the CB 4. 
The animals were administered glucose tolerance tests (GTT) 
at 3, 6, 9, and 12 weeks post infection. Within 7 days after 
the final glucose tolerance test, the animals were fasted 
overnight and all sacrificed. The following parameters were 
examined: concentration of pancreatic protein and insulin; 
concentration of plasma insulin; and serur1 titer of neutralizing 
antibody to the homologous CB 4 virus. 
During the second phase of the exPeriment, 6-7 week old 
male CD-1 mice were divided into 2 groups with 20 animals in 
each group. Each group was inoculated ip with 1 x 10
7 pfu 
of either the Edw isolate or the E2i isolRte of the CB 4. 
Again, glucose tolerance tests were administered at 3, 7, 9, 
and 12 weeks post infection. After 12 weeks post infection, 
three animals from each group were fasted overnight, sacri­
ficed and examined as before. 
Uninfected animals of the same strain, age, and sex were 
carried throughout the experiments. Thev were used as 
controls for each assay conducted on the infected animals. 
V. Techniques 
Glucose Tolerance Test/Glucose Assay 
Glucose Challenge was ac�teved by injecting each animal 
14. 
ip. •·•ith 2 mg of glucose per gram body weight. The glucose 
was a 20% aqueous solution. Ten microliters of tail blood 
was collected prior to challenge and then 30, 60, and 120 
minutes post challenge. 
of 2% perchloric acid. 
Each samole was suspended in 150 µl 
After storing overnight at 4
°
c, the 
samples were centrifuged at ;moo x g for 20 minutes. Fifty 
microliters of the supernatant from each sample was assayed 
for glucose by the glucose oxidase procedure as described by 
Chick. 
28 
Analysis of the Pancreas 
Twelve weeks after infection, the animals were sacri-
ficed and a portion of the endocrine pancreas was removed. 
Sare of the tissue was frozen and t."le rest was fixed in 
neutral buffered formalin. The fixed tissue was imbedded in 
paraffin, sectioned, and stained with hemotoxyin and eosin. 
Other sections were stained for insulin granules by the 
aldehyde fuscin method. 
The frozen tissue was later thawed and weighed. The 
pancreatic tissue was homogenized in 2 mls phosphate buffered 
saline (PBS) per 0.1 g of pancreas. This is the stock homo-
genate from which other dilutions were made for pancreatic 
protein and insulin determinations. 
Protein concentrations were determined by the method of 
Kalb and Bernlohr which uses the ratio of light absorbance 
at 230 and 260 nm and can be expressed by the following 
equation: 
29 
( 183 X A230 - 7
. 5 X A260) · This method of 
15 . 
protein analysis was compared with a standard protein assay 
and found to be comparable for the quantitation of ?rotein 
in pancreatic homogenates and purified solutions of bovine 
serum albumin and hyaluronidase. 
Radioirnrnunoassay, as described by Yalow and modified by 
Weir, was used to determine the concentration of insulin in 
30,31 
the pancreas. This method employed the use of a single 
antibody, guinea pig-antiporcine insulin antibody, charcoal 
dextran (T-70 Pharmcia) extraction. The charcoal pellet was 
counted in a Beckman Gamma 8000 for percent unbound insulin. 
The pancreatic insulin was obtained by extracting 1 ml 
of the pancreatic homogenate overnight at 4
°
c in 1 ml of 2% 
perchloric acid. The extraction solution was diluted in °BS 
to adjust the pH to 7 and to bring the concentration into 
range for the assay. 
Serum Analysis 
The serum of selected animals was collected after 
sacrifice for the analysis of neutralizing antibody. The 
antibody titers were determined using a neutralization test. 
The serum was diluted via a 2 fold serial dilution beginning 
at a 1/40 dilution. Using a 96 well tray, the various 
dilutions of the serum were allowed to react with 100 TCID
50 
of homologous virus for approximately 1. 5 hours at 37
°c. 
BGM cells (105 ) were added to each well and 48 hours later 
the trays were fixed and stained with crystal violet. Anti-
body titers were calculated as the inverse of the highest 
16. 
dilution that exhibited virus neutralization. 
Radioimnunoassay, as described above, was used for the analysis of 
insulin concentrations in the serum.30
, Jl 
Statistical Canparisons 
Statistical Canparisons were made by either a 1-way or a 2-way 
analysis of variance follc:wed by p:>st-hoc canparisons with a Tukey 
test. 'Groups' is defined as weeks p:>st infection. 'Ti.Ire' is defined 
as minutes after glucose challenge. 
Results 
GLucose Tolerance Tests 
Results of individual GTT of mice infected with CB4 Pow 
are shown in Fig. l. When each time at 3, 6, 9, and 12 weeks 
post infection was expressed as a mean and compared with the 
controls, as shown in fig. 2, a definitive pattern aooeared. 
A 4 x 4 ANOVA with repeated measures across time revealed a 
significant effect between groups, F(3,36) =21.57, P<J.001 and 
across times F(3,108)=97.65, P<0.001. In addition, the 
groups by time interaction, F(9,l08)=7.58, p<0.001, was 
significant. Post-hoc comparisons with a Tukey test (P<0.05) 
revealed that the Pow virus was significantly different from 
the control group at 6 weeks (30, 60, and 120 min. post 
challenge) and at 9 weeks (30 and 60 min. post challenge) 
post infection. Data from the 3 mice examined at 12 weeks 
were not included in these comparisons. 
Results of individual GTT mice infected with CB4 Edw are 
shown in fig. 3. When each time at 3, 6, 9, and 12 weeks 
post infection was expressed as a mean and compared with the 
controls, as shown in fig. 4, a definitive pattern appeared. 
A 4 x 4 ANOVA with repeated measures across time revealed a 
significant effect between groups, F(3,37J =29.61, p <0.0001 
18. 
and across times, F(3,110J=66.52, p<0.0001. In addition, the 
groups by times interaction, F(9,ll0)=4.75, p<0.001, was 
significant. Post-hoc comparisons with a Tukey test (r<0.05) 
revealed that the Ectw virus was significantly different from 
the control group at 6 weeks (30, 60, and 120 min. post chal­
lenge) and at 9 weeks (30 and 60 min. oost challenge) post 
infection. Data from the 3 mice examined at 12 weeks were 
not included in these comparisons. 
Figure 1: Results of individual GIT of mice infected with CB4 Pew at 
a.) 3 weeks post infection, b.) 6 weeks post infection, c.) 
9 weeks post infection, and d.) 12 weeks post infection. 
The line represents the !refill non-fasting glucose level 
of the control animals. 
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Figure 2: Results of individual GIT of mice infected with CB4 �' 
expessed as means and cx:impared to the IIEan values of 
the results of individual GIT of the control mice. 
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Figure 3: Results of individual GIT of mice infected with CB4 F.dw at 
a.) 3 weeks post infection, b.) 6 weeks post infection, c.) 
9 weeks post infection, and d.) 12 weeks post infection. 
The dotted line represents the rrean non-fasting glucose 
level of the control animals. 
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Figure 4: The results of the individual GIT of mice indected with CB4 
Edw expressed as rreans and canpared to the mean values of 
the results of individual GIT of control mice. 
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Results of individual GTT of mice infected with CB4 El 
are shown in fig. 5. When each time at 3, 6, 9, and 12 weeks 
post infection are expressed as a mean and com9ared with the 
controls, as shown in fig. 6, a definitive pattern appeared. 
A 4 x 4 ANOVA with reoeated measures across times revealed a 
significant effP.ct between grouDs, F(3,36)=35.26, n<0.001 and 
across time, F(3,108)=58.59, p<0.001. In addition, the groucs 
by time interaction, F(9,108)=5.17, o<0.001, was significant. 
Post-hoc comparisons with a Tukey test (r,<0.05) revealed that 
El was significantly different form the control group at 6 
weeks (30, 60, and 120 min. post challenge) and at 9 weeks 
(30, 60, and 120 min. post challenge) post infection. Data 
from the 3 mice examined at 12 weeks were not included in 
these experiments. 
Results of individual GTT of mice infected with CB4 E2 
are shown in fig. 7. \�hen each time at 3, 6, 9, and 12 weeks 
post infection was exoressed as a mean and compared with the 
controls, as shown in fig. 8, a definitive·pattern aoceared. 
A 4 x 4 ANOV� with repeated measures across time revealed a 
significant effect between grou?S, F(3,36)=7.65, r <0.001 and 
across times, F(3,10�)=72.18, p<0.001. In addition, the 
groups by time interaction, F(9,108)=5.86, r< 0.001, was signi­
ficant. Post-hoc comparisons with a Tukey test (p<0.05) 
revealed that E2 was significantly different from the control 
group at 3 weeks (30 min. cost challenge), 6 weeks (30, 60, 
120 min. post challenge), and 9 weeks (30, 60, and 120 min. 
28. 
post challenge) post infection. Data from the 3 mice 
examined at 12 weeks were not included 1n these comparisons. 
Figure 5: Results of individual GIT of mice infected with CB4 El 
at a.) 3 weeks post infection, b.) 6 weeks post infection, 
c.) 9 weeks post infection, and d.) 12 weeks post infection. 
The dotted line represents the mean non-fasting glucose 
level of the control animals. 
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Figure 6: The results of the individual GIT of mice infected with CB4 
El expressed as rreans and c::arpared to the mean values of 
the results of individual GIT of the control mice. 
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Figure 7: Results of individual GIT of mice infected with CB4 E2 at 
a.) 3 weeks post infection, b.) 6 weeks post infection, c.) 
9 weeks post infection, and d.) 12 weeks post infection. 
The dotted line represents the rrean non-fasting glucose 
level of the control animals. 
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Figure 8: The results of the individual GIT of mice infected with 
CB4 E2 expressed as means and cx:rnpared to the mean values 
of the results of individual GIT of control mice. 
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Results of individual GTT of mice infected with CB4 E3 
are shown in fig. 9. \�hen each time at 3, 6, 9, and 12 weeks 
post infection was expressed as a mean and compared with the 
controls, as shown in fig. 10, a definitive pattern appeared. 
A 4 x 4 ANOVA with repeated measures across times revealed a 
significant effect between groups, F(3,37J=l5.90, n<0.001 and 
across times, F(3,111)=91.72, p<0.001. In addition, the 
groups by time interaction, F(9,111)=6,63, p<0.001, was signi­
ficant. Post-hoc comoarisons with a Tukey test (p<0.05) 
revealed that E3 was significantly different from the control 
group at 3 weeks (30, 60, and lLO min. post challenge), 6 
weeks (30, 60, and 120 min. post challenge), and 9 weeks (30, 
60, and 120 min. post challenge) post infection. Data from 
the 3 mice examined at 12 weeks were not included in these 
comparisons. 
Results of individual GTT of mice infected with CB4 E2i 
are shown in fig. 11. When each time at 3, 6, 9, and 12 
weeks post infection was expressed as a mean and compared 
with the controls, as shown in fig. 12, a definitive pattern 
appears. A 4 x 4 ANOVA with repeated measures across times 
revealed a significant effect between groups, F(J,37)=8.67, 
p<0.001 and across time, F(3,lllJ=72.87, p<0.001. In 
addition, the groups by time interaction, F(9, 11 1)=6.08, 
P<0.001, was significant. Post-hoc comparisons with a Tukey 
test (p<0.05) revealed that E2i was significantly different 
from the control group at 3 weeks (30 and 60 min. oost 
38. 
challenge), 6 weeks (30 and 60 min. post challenge), and 9 
weeks (30 and 60 min. post challenge) post infection. Data 
from the 3 mice examined at 12 weeks were not included in 
these comparisons. 
Figure 9: Results of individual GIT of mice infected with CB4 E3 
at a.) 3 weeks post infection, b.) 6 weeks post infection, 
c.) 9 weeks post infection, and d.) 12 weeks post infection. 
The dotted line represents the rrean non-fasting glucose 
level of the control a.nirrials. 
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Figure 10: The results of individual GIT of mice infected with CB4 E3 
expressed as means and canpared to the mean values of the 
results of individual GIT of a:mtrol mice. 
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Figure 11: Results of individual GIT of mice infected with CB4 E2i 
at a.) 3 weeks post infection, b.) 6 weeks post infection, 
c.) 9 weeks post infection, and d.) 12 weeks post infection. 
The dotted line represents the rrean non-fasting glucose 
level of the control animals. 
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Figure 12: The results of individual GIT of mice infected with CB4 E2i 
expressed as means and carpared to the mean values of the 
results of individual GIT of control mice. 
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47. 
In the above phase of the experiment, the animals were 
inoculated with a single dose of 10
4 
pfu of virus. A second 
phase of the experiment was conducted to determine if dose 
had any effect on the results. In this phase, the animals 
were inoculated with a single intraperitoneal dose containing 
10
7 
pfu of either Edw or E2i virus. The results of individual 
GTT of mice inJected with CB4 Edw high dose (Edw') are shown 
in fig. lJ. When each time at 3, 6, 9, and 12 weeks post 
infection was expressed as a mean and compared with the 
controls, as shown in fig. 14, a definitive pattern appears. 
There was an obvious increase in the post challenged blood 
glucose levels at 6, 9, and 12 weeks post infection, 
indicating glucose intolerance. Edw' also induced an 
increased mortality. There was less than 5% mortality in 
all other groups, however, the group inoculated with Edw' had 
4 0% mortality. 
The results of individual GTT of mice in1ected with CB4 
E2i high dose (E2i') are shown in fig. 15. When each time at 
3, 6, 9, and 12 weeks post infection was expressed as a mean 
and compared with the controls, as shown in fig. 16, a 
definitive pattern appeared. There was an obvious increase 
in post challenge blood glucose levels at 6, 9, and 12 weeks 
post infection, indicating glucose intolerance. The dose 
effect data £ran infection with Edw' and E2i were included in the 
statistical canparisons below to determine differences between 
viruses. 
Figure 13: Results of individual GIT of mice infected with CB4 E.dw' 
at a.) 3 weeks post infection, b.) 6 weeks post infection, 
c.) 9 weeks post infection, and d.) 12 weeks post infec­
tion. The dotted line represents the rrean non-fasting 
glucose level of the control animals. 

Figure 14: The results of individual GIT of mice infected with CB4 
Edw' expressed as means and canpared to the rrean values of 
the results of individual GIT of control mice. 
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Figure 15: Results of individual GIT of mice infected with CB4 E2i' 
at a.) 3 weeks post infection, b.) 6 weeks post infection, 
c.) 9 weeks post infection, and d.) 12 weeks post infec­
tion. The dotted line represents the rrean non-fasting 
glucose level of the control animals. 
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Figure 16: The results of the individual GIT of mice infected with 
CB4 E2i' expressed as means and caupared to the mean 
values of the results of individual GIT of control mice. 
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A sumnary of the results £ran the GIT analyzed by 4 x 4 NJ.OVA and 
post-hoc canparisons wht Tukey test are sho,m in table 1 with the main 
effects noted for each block canpared with controls. Although there 
were a number of significant effects, three times were chosen for 
furt.hA..r analysis. The 3 weeks post infection at 60 min. post challenge, 
6 weeks post infection at 60 min. post challenge, and 9 weeks post in­
fection at 60 min. post challenge were used to detennine differences 
between virus groups by a 1-way NJ.OVA. At 3 weeks post infection, 60 min. 
post challenge, a 1-way ANOVA revealed a significant effect across 
viruses, F(8,80)=4.30, p<0.05. Post-hoc canparisons with a Tukey test 
(p<0.05) revealed that Edw was significantly different £ran E2, E3, E2i, 
Edw', and E2i', but was not significantly different £ran Po,., or El. 
All other canparisons were not significantly different as sho,m in table 
2. 
At 6 weeks post infection, 60 min. post challenge, a 1-way NJ.OVA 
revealed significant effects across viruses, F(8,81)=6.03, p<0.05. 
Post-hoc canpariscns with a Tukey test (p<0.05) revealed that the con-
trols were significantly different £ran Po,.,, Edw, El, E2, Edw', and 
E2i', but were not significantly different fran E3 and E2i, as sho,m 
in table 2. 
At 9 weeks post infection, 60 min. post challenge, a 1-way NJ.OVA 
revealed significant effects across viruses,F(8,76)=4.09, p<0.05. 
Post-hoc canparisons with a TUkey test (p<0.05) revealed that the 
controls were significantly different £ran El, E2, E3, and E2i', 
but were not significantly different £ran Edw, Po,.,, or E2i. All other 
· not significantly different, as sho,m in table 2. canparisons were 
Table 1. 
0 
Pow -
Edw -
El -
E2 -
E3 -. 
E2i -
Post hoc comparisons of a 4 x 4 ANOVA of 
GTT results. 
3 wks. 6 wks. 9 wks. 
30 60 120 0 30 60 12 0 0 30 60 
- - - - * * * - * * 
- - - - * * * - * * 
- - - - * * * - * * 
* - - - * * * - * * 
* * * - * * * - * * 
* * - - * * - - * * 
57. 
120 
-
-
* 
* 
* 
-
*Significant at p<0.01 when compared to the control group. 
Each virus constituted a separate ANOVA. 
58. 
Table 2. Post-hoc comparisons of 1-way ANOVA of GTT 
results to detect differences between viruses. 
3 Weeks* 6 Weeks 9 Weeks 
E3 A El A E3 
E2i A Pow A E2 
Edw' A E2i' A E2i' 
E2i' A Edw' A El 
E2 A Edw A Edw' 
Pow A B E2 A E2i 
El A B E3 A B Edw 
Controls A B E2i A B Pow 
Edw B Controls B Controls 
A 
A 
A 
A 
A 
A 
A 
A 
*Viruses scored with the same letter are not significantly 
different. 
3 weeks, 6 weeks, and 9 weeks each constitute a separate 
1-way ANOVA 
B 
B 
B 
B 
59. 
Neutralization Test 
Results for neutralizing antibody are shown in table 3. 
Representative animals were selected and examined after 12 
weeks post infection for neutralizing antibody to virus, 
these are the mice for which 12 week GTT were run. The 
presence of neutralizing antibody would be supportive 
evidence that the animals had significant neutralizing anti­
body to the coxsackie virus with which it was inoculated 
(homologous virus/serum reaction). There was no ap�arent 
correlation between GTT results of these individual mice 
and their respective level of antobody to the virus (see 12 
week GTT levels). 
Table 3. Test for Neu tr a lizi ng Antibody. 
Virus 
Pow 
Edw 
El 
E2 
E3 
E2i 
Edw' 
E2i' 
Ab level 
320
a 
320 
320 
160 
160 
160 
160 
320 
40 
1280 
640 
160 
320 
320 
320 
1280 
320 
1280 
160 
160 
80 
640 
640 
320 
a
Antibody ti ters were calculated as the i nverse of the 
highest dilu tion of serum that exhibited virus neutralization. 
Each number represents a different animal. 
60. 
61. 
Serum IRI 
Serum immunoreactive insulin levels were generally quite 
low as detected by our radioinununoassay system. The lack of 
sensitivity of the assay prevented accurate determination of 
serum immunoreactive insulin levels. Therefore, these data 
were not compared statistically and are not presented. 
Histology 
The pancreases of mice from each group were examined by 
light microscopy after staining with hemotoxylin and eosin 
and with aldehyde fuscin. The observations were qualitative 
and no attempt was made to estimate the relative endocrine/ 
exocrine volume. The pancreases of all mice examined were 
unremarkable. 
architecture. 
All showed normal cell confirmation and tissue 
The beta cells in the islets of Langerhans 
from both control and virus grou�s were well granulated with 
insulin. There was no evidence of inflammation, necrosis, 
fatty replacement or other pathologies characteristic of 
acute CB viral infection of the pancreas. 
Extractable Immunoreactive Insulin 
Pancreatic insulin data are shown in fig. 17. �he mean 
level of extractable immunoreactive insulin of controls was 
32 � 16 uU/ug extractable protein. The mean levels of 
extractible immunoreactive insulin at 12 weeks after infection 
with any of the viruses was less than the control level. 
One-way ANOVA, F(6,93)=20.51, p<0.05, showed that there was a 
significant effect across groups. Post-hoc comparisons with 
Figure 17: Mean values ± SD of the extractable pancreatic irrmun.ore­
active insulin expressed as uU of insulin per ug extract­
able protein. 
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64. 
a Tukey test (p<0.05) revealed that all viruses were signifi­
cantly different from the controls. However, there was no 
significant difference between viruses. 
Weights 
All animals were weighed periodically; the primary times 
were before glucose tolerance tests and these weights are 
shown in fig. 18. All animals increased in weight over the 
12 week period. However, most infected animals lost weight 
during the acute stage of infection which was expected. 
Weight has never correlated with viral-induced diabetes in 
mice and thus they were not critically analyzed here. 
Figure 18: Mean values:!: SD of the l:x:xly weights (g) across tirre(wks) 
for controls and each of the virus groups. 
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Discussion 
In recent years, the idea of a viral etiology in 
diabetes mellitus in man has been revived by a few new case 
studies and strong support from numerous experiments with 
mice. The most convincing data have been generated by Yoon 
and Notkins and associates using a laboratory-derived strain 
of encephalomyocarditis (EMC) virus in inbred mice. They 
have, along with others, including Webb and associates, 
shown that the common human virus, Coxsackievirus, group B, 
type 4 (CB4) can cause diabetes-like disease in mice of 
specific genetic background, but not in others. Unlike the 
data presented from this study, most other studies have been 
of a short term nature, that is, most have been terminated 
at or before 3 weeks post infection. If within this brief 
period, the experimental subjects did not (1) exhibit 
abnormal fasting or nonfasting blood glucose levels, (2) have 
inappropriate responses to glucose challenge during GTT, or 
(3) have an abnormal "glucose index", it was concluded that 
the animals were not diabetic. If, however, any one of the 
conditions were detected, it was taken as evidence for viral­
induced diabetes. The latter conclusion was appropriate and 
justified. However, the former conclusion based on negative 
68. 
responses within 3 weeks of infection were apparently not 
true. In light of the new findings detailed in this report, 
the one most important detail in the experimental design may 
not be host genetics or virus genetics, but simply time. 
That is the host and viral genetics undoubtedly exert a 
strong influence on the pathogenesis, but if the experimental 
design precludes detection of subtle changes that do not 
become apparent for several weeks after infection then 
erroneous conclusions are made. 
Using six isolates of CB4, the blood glucose levels 
were monitored for 12 weeks. GTT were performed over the 
period and all data except the 12 week GTT data were subjected 
to statistical analysis. Results of GTT's indicated that 
half of the groups inoculated with the isolates were 
significantly different from the controls at 3 weeks. Thus, 
by most criteria only 3 of the 6 virus isolates would be 
considered diabetogenic. Previously, statistical analysis 
was not applied to the results of GTT. Abnormal blood glucose 
levels have been determined by a glucose index or by other 
requirements such as 3 of the 4 GTT values being elevated. 
By the former analysis, only two of the six isolates used in 
this study would be classified as diabetogenic while analysis 
by the latter, would classify only of of the six isolates as 
diabetogenic. statistical comparisons are, therefore, use-
ful tools in analyzing GTT data, in that they can provide a 
uniform method of analysis and interpretation. 
69. 
Statistical analysis of GTT data at 6 and 9 weeks post 
infection revealed that all virus isolates were significantly 
different from the controls. These elevated blood glucose 
levels indicate glucose intolerance and the viral-inducation 
of diabetes in the experimental animals. Since this condi-
tion was not manifested until 6 weeks post infection, one 
must question the relative weight that should be given to 
data from experiments which were terminated at or before the 
end of 3 weeks post infection. Statistical analysis of the 
extractable pancreatic immunoreactive insulin concentrations 
revealed that all of the virus groups had a significantly 
lower concentration than the control group. The insulin 
data lend support to the observation that the glucose intol-
erance induced in the experimental animals was indeed a 
direct reflection of an insulin deficit. By even the most 
conservative criteria for experimental animals, many of 
these mice would be classified as diabetic. 
Since all six virus isolates did induce diabetes-like 
disease in the mice, I then examined for a dose effect 
using two of the isolates. The results of high dose experi-
ments (10
7 
pfu vs. 10
4
pfu) showed a definitive dose effect 
with both isolates, Edw and E2i, when compared to the data 
of the previous low dose experiment. These data suggest, 
as expected, that dose may influence the ultimate consequence 
of viral infection. 
70. 
Host genetics have been shown to influence the outcome 
of infection with the viruses thought to be capable of 
inducing diabetes. Inbred mice have proved valuable in 
establishing that host genetics does play a major role in 
viral pathogenesis. The use of outbred mice, such as the 
CD-1 strain used in these studies, have generally been dis­
continued since more dramatic viral effects can be demon-
strated in some inbred strains. Outbred mice were chosen 
for this study to help ensure a genetically diverse host 
system so that the specific influence of host genetics could 
be minimized. Thus, interpretation of the results here 
depended mostly upon the other primary variable -- that is 
the virus. 
Virus genetics play an important role in the diabeto-
genie potential of a virus. Hartig and associates and 
Toniolo and associates have demonstrated that intratypic 
variations exist within the CB4 virus. The former used 
clone selectiori by plaque purification, while the latter used 
sequential islet cell passage. Both, however, concluded 
that these variations influence the diabetogenic potential 
of the CB4 virus. The data presented in this study agrees 
and disagrees with their conslusions. At 3 weeks post 
infection, there was a significant difference inthe diabeto­
genic potential of the Edw isolate and all of its clones. 
By six weeks, there was no significant difference in the 
diabetogenic potential of any of the isolates. Therefore, 
71. 
evaluating the ultimate diabetogenic effect of CB4 virus in 
experimental mice, one must consider the results in relation 
to several factors. 
previously believed. 
Time appears to be more critical than 
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